# A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06399757/  
OnCo record `nct06399757` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of APL-5125 in colorectal cancer, biliary tract cancer, appendiceal cancer and pseudomyxoma peritonei, pancreatic ductal adenocarcinoma, gastric & gastro-oesophageal junction cancer and endometrial cancer, run by Apollo Therapeutics Ltd, active and no longer recruiting.

## Summary

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06399757 by Apollo Therapeutics Ltd, with 100 participants enrolled, started 2024-06-18 and due to reach its primary completion in 2027-04. Interventions recorded: APL-5125.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06399757
- Phase: 1/2
- Setting: A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors
- Sponsor: Apollo Therapeutics Ltd
- Enrolled: 100

## Sources

- ClinicalTrials.gov NCT06399757: https://clinicaltrials.gov/study/NCT06399757

## Connected records

- cancers: [Appendiceal cancer and pseudomyxoma peritonei](https://onco.cc/cancers/appendiceal/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Endometrial cancer](https://onco.cc/cancers/endometrial/), [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)

---
JSON: https://onco.cc/api/v1/entities/nct06399757.json